Milstien Julie B, Kamara Lidija, Lydon Patrick, Mitchell Violaine, Landry Steve
University of Maryland School of Medicine, 3 bis rue des Coronilles, Res Parc de Clementville, Bat C, 34070 Montpellier, France.
Vaccine. 2008 Dec 2;26(51):6699-705. doi: 10.1016/j.vaccine.2008.07.061.
The Global Alliance for Vaccines and Immunization, now called the GAVI Alliance, was launched in 2000 as a coalition of partners, including countries, international organizations, bilateral donors, the vaccine production industry, and nongovernmental organizations; most activities were to be implemented through these partner organizations. Four task forces were established at the outset to define issues relevant to GAVI Alliance goals and to recommend actions. This paper describes the innovations and outputs of the Financing Task Force (FTF), which worked in three areas: country support to sustainably finance vaccines and immunization programs in the context of introducing new vaccines; vaccine supply and demand issues as they impact vaccine choice, production costs and price/dose; innovative financing mechanisms for vaccines and immunization programs through, for example, capital markets. This analysis particularly focuses on the FTF's work on financial sustainability. Through its partnership, the FIF was able to leverage organizational change in its participating organizations, in the countries supported by the GAVI Alliance, and in the policies of GAVI itself. These achievements, along with areas where the desired outcome was not achieved, are summarized with lessons that may be useful to other multi-partner health alliances.
全球疫苗免疫联盟(现称为GAVI联盟)于2000年发起成立,是一个由各国、国际组织、双边捐助方、疫苗生产行业和非政府组织等合作伙伴组成的联盟;多数活动将通过这些伙伴组织来实施。一开始设立了四个特别工作组,以确定与GAVI联盟目标相关的问题并建议采取行动。本文介绍了融资特别工作组(FTF)的创新举措和成果,该工作组在三个领域开展工作:在引入新疫苗的背景下为可持续资助疫苗和免疫规划提供国家支持;疫苗供需问题对疫苗选择、生产成本和每剂价格的影响;通过资本市场等途径为疫苗和免疫规划提供创新融资机制。本分析尤其侧重于融资特别工作组在财务可持续性方面的工作。通过其伙伴关系,融资特别工作组能够促使其参与组织、GAVI联盟所支持国家以及GAVI自身政策发生组织变革。这些成就以及未实现预期成果的领域,均总结了可能对其他多伙伴卫生联盟有用的经验教训。